(WRIC) — An intravenous (IV) fluid shortage in the wake of Hurricane ... The company has also received approval from the Food ...

U.S. hospitals are experiencing a shortage of IV fluids, triggered by a disruption at Baxter's North Carolina plant following Hurricane Helene. As hospitals have scrambled to conserve supplies, at ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Hospira’s original biosimilar portfolio has been merged with other divisions within Pfizer, and the global infusion therapy ...

When Hurricane Milton barreled through the Gulf of Mexico with a ferocity that brought one Florida-based meteorologist to tears, Beth Gore’s biggest worry wasn’t ...

The home infusion industry is experiencing significant growth due to the increasing number of aging patients wanting to ...

A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy ...

Placement funds will accelerate TYP’s development of its lead program TRP-8803, which is a novel and scalable IV-infused psilocin ... as a leading psychedelic drug developer.

Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced today. Along ...

Jet lag is a common travel nuisance that can turn an exciting journey into an exhausting ordeal. It occurs when there’s a mismatch between your internal body clock and the new time zone you’re in.

Hospitals in the region are grappling with an ongoing shortage of IV fluids, a situation exacerbated by hurricane damage.

GRCE READ THE FULL GRCE RESEARCH REPORT We are initiating coverage of Grace Therapeutics, Inc. (NASDAQ:GRCE) with a valuation of $12.50 per share. This value is based on our estimates for the ...